The SPDR S&P Biotech ETF (XBI) reported a week-over-week outflow of approximately $234.1 million, marking a 2.1% decrease in shares outstanding, from 69,100,000 to 67,675,000. Key underlying components include Apogee Therapeutics Inc (APGE), down 0.1%; Kymera Therapeutics Inc (KYMR), down 2.5%; and Twist Bioscience Corp (TWST), down 4.8%.
The ETF’s 52-week low is $84.39 per share, while its high is $165.71, with the latest trade at $157.38. The outflow may influence the underlying assets as units are destroyed in response to investor demand.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
